The Effect of Virgin Coconut Oil on Lipid Profile and Fasting Blood Sugar: A Phase I Clinical Trial

Cecille R Dela Paz, C. Jimeno, R. Sy, F. Punzalan, P. D. Pena
{"title":"The Effect of Virgin Coconut Oil on Lipid Profile and Fasting Blood Sugar: A Phase I Clinical Trial","authors":"Cecille R Dela Paz, C. Jimeno, R. Sy, F. Punzalan, P. D. Pena","doi":"10.3860/PJIM.V48I2.2632","DOIUrl":null,"url":null,"abstract":"Background: Virgin coconut oil (VCO) is promoted as a dietary supplement for people with various ailments. However, there have been few formal scientific studies to validate its health benefits. Objective: To determine the effect of VCO on lipid profile, FBS, weight and body mass index (BMI) of healthy humans and evaluate its safety profile by determining effect on creatinine, potassium, AST, ALT and CBC Methods: Weight and height were obtained from 30 healthy males and BMI was computed on first visit. Baseline laboratories were taken: FBS, 2-hour glucose after 75 gram oral glucose, total cholesterol, triglyceride, LDL, HDL, creatinine, potassium, AST and ALT, and CBC. Each subject took VCO 15 mL t.i.d. before meals. After 6 weeks, repeat laboratory examinations were done. Weight was taken and BMI recomputed. Adverse events were reported. Results: There was significant increase in mean FBS (76.03, 6.62 mg/dl to 80.11, 9.04 mg/dl, p=0.024), significant decrease in HDL (47.58, 7.54 to 44.09, 7.10, p=0.028), significant increase in creatinine (76.44, 9.88 umol/L to 82.99, 11.29 umol/L, p = 0.0002) and platelet count (281.03, 52.6 x 109/L to 295.1, 58.06 x 109/L, p = 0.040) and significant decrease in WBC count (7.63, 1.74 x 109/L to 6.85, 1.5 x 109/L, p = 0.012). There was no effect on the rest of the laboratory examinations done. Twenty participants reported mild gastrointestinal (GI) complaints, including diarrhea (8), abdominal pain (3), diarrhea and abdominal pain (5), and diarrhea and vomiting (4). Conclusion: VCO significantly increases FBS and decreases HDL. VCO also increases creatinine and platelet count and decreases WBC count. Mild GI complaints were the most commonly reported adverse events. Further studies may be needed in order to validate the results of this exploratory study and elucidate the metabolic effects of VCO. Keywords: virgin coconut oil; metabolic effect; lipid profile Philippine Journal of Internal Medicine, Vol. 48 No. 2: Jul-Sep 2010, pp 1-6","PeriodicalId":85270,"journal":{"name":"Philippine journal of internal medicine","volume":"48 1","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2012-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Philippine journal of internal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3860/PJIM.V48I2.2632","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12

Abstract

Background: Virgin coconut oil (VCO) is promoted as a dietary supplement for people with various ailments. However, there have been few formal scientific studies to validate its health benefits. Objective: To determine the effect of VCO on lipid profile, FBS, weight and body mass index (BMI) of healthy humans and evaluate its safety profile by determining effect on creatinine, potassium, AST, ALT and CBC Methods: Weight and height were obtained from 30 healthy males and BMI was computed on first visit. Baseline laboratories were taken: FBS, 2-hour glucose after 75 gram oral glucose, total cholesterol, triglyceride, LDL, HDL, creatinine, potassium, AST and ALT, and CBC. Each subject took VCO 15 mL t.i.d. before meals. After 6 weeks, repeat laboratory examinations were done. Weight was taken and BMI recomputed. Adverse events were reported. Results: There was significant increase in mean FBS (76.03, 6.62 mg/dl to 80.11, 9.04 mg/dl, p=0.024), significant decrease in HDL (47.58, 7.54 to 44.09, 7.10, p=0.028), significant increase in creatinine (76.44, 9.88 umol/L to 82.99, 11.29 umol/L, p = 0.0002) and platelet count (281.03, 52.6 x 109/L to 295.1, 58.06 x 109/L, p = 0.040) and significant decrease in WBC count (7.63, 1.74 x 109/L to 6.85, 1.5 x 109/L, p = 0.012). There was no effect on the rest of the laboratory examinations done. Twenty participants reported mild gastrointestinal (GI) complaints, including diarrhea (8), abdominal pain (3), diarrhea and abdominal pain (5), and diarrhea and vomiting (4). Conclusion: VCO significantly increases FBS and decreases HDL. VCO also increases creatinine and platelet count and decreases WBC count. Mild GI complaints were the most commonly reported adverse events. Further studies may be needed in order to validate the results of this exploratory study and elucidate the metabolic effects of VCO. Keywords: virgin coconut oil; metabolic effect; lipid profile Philippine Journal of Internal Medicine, Vol. 48 No. 2: Jul-Sep 2010, pp 1-6
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
初榨椰子油对血脂和空腹血糖的影响:一期临床试验
背景:初榨椰子油(VCO)被推广为各种疾病患者的膳食补充剂。然而,很少有正式的科学研究来证实它对健康的好处。目的:探讨VCO对健康人血脂、FBS、体重和体质指数(BMI)的影响,并通过测定其对肌酐、钾、AST、ALT和CBC的影响来评价其安全性。方法:获取30例健康男性的体重和身高,首次就诊时计算BMI。基线实验:FBS、口服葡萄糖75克后2小时葡萄糖、总胆固醇、甘油三酯、LDL、HDL、肌酐、钾、AST和ALT、CBC。每名受试者每日饭前服用VCO 15 mL。6周后复查实验室检查。测量体重并重新计算BMI。有不良事件报告。结果:患者平均FBS(76.03、6.62 mg/dl至80.11、9.04 mg/dl, p=0.024)显著增高,HDL(47.58、7.54、44.09、7.10,p=0.028)显著增高,肌酐(76.44、9.88 umol/L至82.99、11.29 umol/L, p= 0.0002)显著增高,血小板计数(281.03、52.6 × 109/L至295.1、58.06 × 109/L, p= 0.040)显著降低,白细胞计数(7.63、1.74 × 109/L至6.85、1.5 × 109/L, p= 0.012)。这对其他实验室检查没有影响。20名参与者报告了轻微的胃肠道(GI)症状,包括腹泻(8)、腹痛(3)、腹泻和腹痛(5)、腹泻和呕吐(4)。结论:VCO显著增加FBS,降低HDL。VCO还增加肌酐和血小板计数,降低白细胞计数。轻度胃肠道疾病是最常见的不良事件。为了验证这一探索性研究的结果并阐明VCO的代谢作用,可能需要进一步的研究。关键词:初榨椰子油;代谢效果;菲律宾内科杂志,Vol. 48 No. 2: 2010年7 - 9月,pp . 1-6
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Perceived Negligence: Why Patients Sue? The Effect of Virgin Coconut Oil on Lipid Profile and Fasting Blood Sugar: A Phase I Clinical Trial Escitalopram in Philippine Clinical Practice: Result of an Open-label, Observational Study in 2920 Outpatients with Depression Prevalence and Treatment of Chronic Pain in the Philippines Unraveling the Enigma of Bangungut: Is Sudden Unexplained Nocturnal Death Syndrome (SUNDS) in the Philippines a Disease Allelic to the Brugada Syndrome?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1